Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells

Fig. 3

Viability analysis of H295R cells treated with mitotane. a MTS assay in monolayer cells after mitotane treatment for 3 days; b MTS assay in spheroids after treatment for 72 h; c phase-contrast photomicrography of spheroids after 72 h; d confocal microscopy images of spheroids after 30 μM mitotane treatment (100 μm). The results are expressed as the mean ± SE; ANOVA *p < 0.05; ***p < 0.001; ****p < 0.0001; n = 3

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us